Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population
1 other identifier
observational
108
1 country
1
Brief Summary
The study is a survey to answer the specific question, "What is the prevalence of metabolic syndrome in maintenance hemodialysis patients?" Metabolic syndrome is a cluster of conditions that increase an individual's risk for developing cardiovascular disease and diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 4, 2010
CompletedFirst Posted
Study publicly available on registry
August 6, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFebruary 27, 2012
February 1, 2012
4 months
August 4, 2010
February 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of maintenance patients with at least three risk factors of metabolic syndrome
6 months
Eligibility Criteria
All study subjects are on maintenance hemodialysis
You may qualify if:
- Patients undergoing maintenance hemodialysis equal to or greater than 3 months
- Patient at lest 18 years of age
- Availability of all data in the medical record for classification of the metabolic syndrome, including serum triglycerides, serum HDL-cholesterol, systolic BP and diastolic BP, and serum glucose
You may not qualify if:
- Patients unwilling or unable to give informed consent to participate
- Patients with a history of thyroid disease
- Patients unable to stand upright
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Winthrop University Hospital Outpatient Dialysis Unit
Mineola, New York, 11501, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Schanler, MS, RD
Winthrop University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Administrative Dietitian
Study Record Dates
First Submitted
August 4, 2010
First Posted
August 6, 2010
Study Start
August 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
February 27, 2012
Record last verified: 2012-02